COVID-19 Impact on Global Tauopathies Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 90 pages | ID: C3ED767F3A6CEN
QYResearch

Abstracts

This report focuses on the global Tauopathies Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Tauopathies Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Bristol-Myers Squibb Company
• Selvita S.A
• SK Biopharmaceuticals Co., Ltd.
• Chronos Therapeutics Limited

Market segment by Type, the product can be split into

• SEL-141
• RDC-5
• YM-08
• Thiamet-G
• Others

Market segment by Application, split into

• Clinic
• Hospital
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Tauopathies Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Tauopathies Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Tauopathies Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tauopathies Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Tauopathies Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 SEL-141
  1.4.3 RDC-5
  1.4.4 YM-08
  1.4.5 Thiamet-G
  1.4.6 Others
1.5 Market by Application
  1.5.1 Global Tauopathies Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Clinic
  1.5.3 Hospital
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Tauopathies Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Tauopathies Treatment Industry
    1.6.1.1 Tauopathies Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Tauopathies Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Tauopathies Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Tauopathies Treatment Market Perspective (2015-2026)
2.2 Tauopathies Treatment Growth Trends by Regions
  2.2.1 Tauopathies Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Tauopathies Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Tauopathies Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Tauopathies Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Tauopathies Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Tauopathies Treatment Players by Market Size
  3.1.1 Global Top Tauopathies Treatment Players by Revenue (2015-2020)
  3.1.2 Global Tauopathies Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Tauopathies Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tauopathies Treatment Market Concentration Ratio
  3.2.1 Global Tauopathies Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Tauopathies Treatment Revenue in 2019
3.3 Tauopathies Treatment Key Players Head office and Area Served
3.4 Key Players Tauopathies Treatment Product Solution and Service
3.5 Date of Enter into Tauopathies Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Tauopathies Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tauopathies Treatment Forecasted Market Size by Type (2021-2026)

5 TAUOPATHIES TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Tauopathies Treatment Market Size by Application (2015-2020)
5.2 Global Tauopathies Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Tauopathies Treatment Market Size (2015-2020)
6.2 Tauopathies Treatment Key Players in North America (2019-2020)
6.3 North America Tauopathies Treatment Market Size by Type (2015-2020)
6.4 North America Tauopathies Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Tauopathies Treatment Market Size (2015-2020)
7.2 Tauopathies Treatment Key Players in Europe (2019-2020)
7.3 Europe Tauopathies Treatment Market Size by Type (2015-2020)
7.4 Europe Tauopathies Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Tauopathies Treatment Market Size (2015-2020)
8.2 Tauopathies Treatment Key Players in China (2019-2020)
8.3 China Tauopathies Treatment Market Size by Type (2015-2020)
8.4 China Tauopathies Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Tauopathies Treatment Market Size (2015-2020)
9.2 Tauopathies Treatment Key Players in Japan (2019-2020)
9.3 Japan Tauopathies Treatment Market Size by Type (2015-2020)
9.4 Japan Tauopathies Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Tauopathies Treatment Market Size (2015-2020)
10.2 Tauopathies Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tauopathies Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tauopathies Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Tauopathies Treatment Market Size (2015-2020)
11.2 Tauopathies Treatment Key Players in India (2019-2020)
11.3 India Tauopathies Treatment Market Size by Type (2015-2020)
11.4 India Tauopathies Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Tauopathies Treatment Market Size (2015-2020)
12.2 Tauopathies Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tauopathies Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tauopathies Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Bristol-Myers Squibb Company
  13.1.1 Bristol-Myers Squibb Company Company Details
  13.1.2 Bristol-Myers Squibb Company Business Overview and Its Total Revenue
  13.1.3 Bristol-Myers Squibb Company Tauopathies Treatment Introduction
  13.1.4 Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2015-2020))
  13.1.5 Bristol-Myers Squibb Company Recent Development
13.2 Selvita S.A
  13.2.1 Selvita S.A Company Details
  13.2.2 Selvita S.A Business Overview and Its Total Revenue
  13.2.3 Selvita S.A Tauopathies Treatment Introduction
  13.2.4 Selvita S.A Revenue in Tauopathies Treatment Business (2015-2020)
  13.2.5 Selvita S.A Recent Development
13.3 SK Biopharmaceuticals Co., Ltd.
  13.3.1 SK Biopharmaceuticals Co., Ltd. Company Details
  13.3.2 SK Biopharmaceuticals Co., Ltd. Business Overview and Its Total Revenue
  13.3.3 SK Biopharmaceuticals Co., Ltd. Tauopathies Treatment Introduction
  13.3.4 SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2015-2020)
  13.3.5 SK Biopharmaceuticals Co., Ltd. Recent Development
13.4 Chronos Therapeutics Limited
  13.4.1 Chronos Therapeutics Limited Company Details
  13.4.2 Chronos Therapeutics Limited Business Overview and Its Total Revenue
  13.4.3 Chronos Therapeutics Limited Tauopathies Treatment Introduction
  13.4.4 Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2015-2020)
  13.4.5 Chronos Therapeutics Limited Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Tauopathies Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Tauopathies Treatment Revenue
Table 3. Ranking of Global Top Tauopathies Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tauopathies Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of SEL-141
Table 6. Key Players of RDC-5
Table 7. Key Players of YM-08
Table 8. Key Players of Thiamet-G
Table 9. Key Players of Others
Table 10. COVID-19 Impact Global Market: (Four Tauopathies Treatment Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for Tauopathies Treatment Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for Tauopathies Treatment Players to Combat Covid-19 Impact
Table 15. Global Tauopathies Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global Tauopathies Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global Tauopathies Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global Tauopathies Treatment Market Share by Regions (2015-2020)
Table 19. Global Tauopathies Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global Tauopathies Treatment Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. Tauopathies Treatment Market Growth Strategy
Table 25. Main Points Interviewed from Key Tauopathies Treatment Players
Table 26. Global Tauopathies Treatment Revenue by Players (2015-2020) (Million US$)
Table 27. Global Tauopathies Treatment Market Share by Players (2015-2020)
Table 28. Global Top Tauopathies Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tauopathies Treatment as of 2019)
Table 29. Global Tauopathies Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players Tauopathies Treatment Product Solution and Service
Table 32. Date of Enter into Tauopathies Treatment Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Tauopathies Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. Global Tauopathies Treatment Market Size Share by Type (2015-2020)
Table 36. Global Tauopathies Treatment Revenue Market Share by Type (2021-2026)
Table 37. Global Tauopathies Treatment Market Size Share by Application (2015-2020)
Table 38. Global Tauopathies Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. Global Tauopathies Treatment Market Size Share by Application (2021-2026)
Table 40. North America Key Players Tauopathies Treatment Revenue (2019-2020) (Million US$)
Table 41. North America Key Players Tauopathies Treatment Market Share (2019-2020)
Table 42. North America Tauopathies Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. North America Tauopathies Treatment Market Share by Type (2015-2020)
Table 44. North America Tauopathies Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. North America Tauopathies Treatment Market Share by Application (2015-2020)
Table 46. Europe Key Players Tauopathies Treatment Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players Tauopathies Treatment Market Share (2019-2020)
Table 48. Europe Tauopathies Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. Europe Tauopathies Treatment Market Share by Type (2015-2020)
Table 50. Europe Tauopathies Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. Europe Tauopathies Treatment Market Share by Application (2015-2020)
Table 52. China Key Players Tauopathies Treatment Revenue (2019-2020) (Million US$)
Table 53. China Key Players Tauopathies Treatment Market Share (2019-2020)
Table 54. China Tauopathies Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. China Tauopathies Treatment Market Share by Type (2015-2020)
Table 56. China Tauopathies Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. China Tauopathies Treatment Market Share by Application (2015-2020)
Table 58. Japan Key Players Tauopathies Treatment Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players Tauopathies Treatment Market Share (2019-2020)
Table 60. Japan Tauopathies Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Japan Tauopathies Treatment Market Share by Type (2015-2020)
Table 62. Japan Tauopathies Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Japan Tauopathies Treatment Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players Tauopathies Treatment Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players Tauopathies Treatment Market Share (2019-2020)
Table 66. Southeast Asia Tauopathies Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia Tauopathies Treatment Market Share by Type (2015-2020)
Table 68. Southeast Asia Tauopathies Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia Tauopathies Treatment Market Share by Application (2015-2020)
Table 70. India Key Players Tauopathies Treatment Revenue (2019-2020) (Million US$)
Table 71. India Key Players Tauopathies Treatment Market Share (2019-2020)
Table 72. India Tauopathies Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. India Tauopathies Treatment Market Share by Type (2015-2020)
Table 74. India Tauopathies Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. India Tauopathies Treatment Market Share by Application (2015-2020)
Table 76. Central & South America Key Players Tauopathies Treatment Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players Tauopathies Treatment Market Share (2019-2020)
Table 78. Central & South America Tauopathies Treatment Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America Tauopathies Treatment Market Share by Type (2015-2020)
Table 80. Central & South America Tauopathies Treatment Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America Tauopathies Treatment Market Share by Application (2015-2020)
Table 82. Bristol-Myers Squibb Company Company Details
Table 83. Bristol-Myers Squibb Company Business Overview
Table 84. Bristol-Myers Squibb Company Product
Table 85. Bristol-Myers Squibb Company Revenue in Tauopathies Treatment Business (2015-2020) (Million US$)
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Selvita S.A Company Details
Table 88. Selvita S.A Business Overview
Table 89. Selvita S.A Product
Table 90. Selvita S.A Revenue in Tauopathies Treatment Business (2015-2020) (Million US$)
Table 91. Selvita S.A Recent Development
Table 92. SK Biopharmaceuticals Co., Ltd. Company Details
Table 93. SK Biopharmaceuticals Co., Ltd. Business Overview
Table 94. SK Biopharmaceuticals Co., Ltd. Product
Table 95. SK Biopharmaceuticals Co., Ltd. Revenue in Tauopathies Treatment Business (2015-2020) (Million US$)
Table 96. SK Biopharmaceuticals Co., Ltd. Recent Development
Table 97. Chronos Therapeutics Limited Company Details
Table 98. Chronos Therapeutics Limited Business Overview
Table 99. Chronos Therapeutics Limited Product
Table 100. Chronos Therapeutics Limited Revenue in Tauopathies Treatment Business (2015-2020) (Million US$)
Table 101. Chronos Therapeutics Limited Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Tauopathies Treatment Market Share by Type: 2020 VS 2026
Figure 2. SEL-141 Features
Figure 3. RDC-5 Features
Figure 4. YM-08 Features
Figure 5. Thiamet-G Features
Figure 6. Others Features
Figure 7. Global Tauopathies Treatment Market Share by Application: 2020 VS 2026
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Tauopathies Treatment Report Years Considered
Figure 12. Global Tauopathies Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Tauopathies Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Tauopathies Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Tauopathies Treatment Market Share by Players in 2019
Figure 17. Global Top Tauopathies Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tauopathies Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Tauopathies Treatment Revenue in 2019
Figure 19. North America Tauopathies Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Tauopathies Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Tauopathies Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Tauopathies Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Tauopathies Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Tauopathies Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Tauopathies Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bristol-Myers Squibb Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Bristol-Myers Squibb Company Revenue Growth Rate in Tauopathies Treatment Business (2015-2020)
Figure 28. Selvita S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Selvita S.A Revenue Growth Rate in Tauopathies Treatment Business (2015-2020)
Figure 30. SK Biopharmaceuticals Co., Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. SK Biopharmaceuticals Co., Ltd. Revenue Growth Rate in Tauopathies Treatment Business (2015-2020)
Figure 32. Chronos Therapeutics Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Chronos Therapeutics Limited Revenue Growth Rate in Tauopathies Treatment Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed